Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,915 | 27,688 | 102,698 | 16,952 | 15,508 |
| Marketable Securities | 61,146 | 61,353 | 7,925 | 23,263 | 36,144 |
| Other current assets | 2,003 | 0 | 0 | 0 | 0 |
| TOTAL | $111,713 | $98,018 | $115,287 | $44,125 | $55,757 |
| Non-Current Assets | |||||
| PPE Net | 72,541 | 55,864 | 58,615 | 58,539 | 60,501 |
| Investments And Advances | 8,799 | 10,022 | 9,253 | 9,253 | 10,750 |
| Intangibles | 1,463 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 26,865 | 16,631 | 13,009 | 15,106 | 16,115 |
| TOTAL | $109,668 | $82,517 | $80,877 | $82,898 | $87,366 |
| Total Assets | $221,381 | $180,535 | $196,164 | $127,023 | $143,123 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,348 | 7,516 | 6,199 | 4,001 | 2,235 |
| Accrued Expenses | 36,771 | 5,497 | 7,449 | 6,634 | 5,343 |
| Other current liabilities | N/A | 2,299 | 3,401 | 3,613 | 775 |
| TOTAL | $68,134 | $20,663 | $17,049 | $14,248 | $11,559 |
| Non-Current Liabilities | |||||
| Long Term Debt | 254,353 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 18,016 | 11,817 | 10,040 | 10,569 | 10,885 |
| TOTAL | $271,737 | $11,250 | $9,462 | $10,180 | $10,885 |
| Total Liabilities | $339,871 | $31,913 | $26,511 | $24,428 | $22,444 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 109,345 | 108,593 | 107,971 | 98,509 | 98,483 |
| Common Shares | 38 | 11 | 11 | 10 | 10 |
| Retained earnings | -1,615,131 | -722,442 | -700,666 | -680,574 | -662,191 |
| Other shareholders' equity | 1,440 | -117 | -100 | -128 | -105 |
| TOTAL | $-118,490 | $148,622 | $169,653 | $102,595 | $120,679 |
| Total Liabilities And Equity | $221,381 | $180,535 | $196,164 | $127,023 | $143,123 |